James Hardie Industries plc (JHX) concluded trading on Wednesday at a closing price of $26.65, with 7.35 million shares of worth about $195.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.39% during that period and on July 16, 2025 the price saw a gain of about 1.95%. Currently the company’s common shares owned by public are about 578.60M shares, out of which, 574.92M shares are available for trading.
Stock saw a price change of -4.07% in past 5 days and over the past one month there was a price change of 1.45%. Year-to-date (YTD), JHX shares are showing a performance of -20.80% which decreased to -13.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.72 but also hit the highest price of $43.57 during that period. The average intraday trading volume for James Hardie Industries plc shares is 5.42 million. The stock is currently trading 0.09% above its 20-day simple moving average (SMA20), while that difference is up 4.16% for SMA50 and it goes to -11.45% lower than SMA200.
James Hardie Industries plc (NYSE: JHX) currently have 578.60M outstanding shares and institutions hold larger chunk of about 6.61% of that.
The stock has a current market capitalization of $15.42B and its 3Y-monthly beta is at 1.76. PE ratio of stock for trailing 12 months is 27.22, while it has posted earnings per share of $0.98 in the same period. Its PEG reads 2.71 and has Quick Ratio of 1.67 while making debt-to-equity ratio of 0.56. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for JHX, volatility over the week remained 3.44% while standing at 3.51% over the month.
Stock’s fiscal year EPS is expected to drop by -6.74% while it is estimated to increase by 17.04% in next year. EPS is likely to shrink at an annualized rate of 10.06% for next 5-years, compared to annual growth of 12.45% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on July 11, 2025 offering an Outperform rating for the stock and assigned a target price of $32 to it. Stock get a Neutral rating from Macquarie on March 24, 2025.
